Tuesday, November 3, 2026

Celltrion expands U.S. PBM coverage, boosting outlook for high-margin biosimilars

Celltrion expands its listing with US PBM, enhancing its high-profit biosimilar product base and boosting sales expectations for H2.

Cat Qubits in AWS’s Ocelot Chip Could Cut Quantum Error Correction Costs by 90%

AWS's new cat qubit could reduce quantum error correction costs by 90%, enhancing quantum computing's commercial viability.

NO TIME TO RUN: Kim’s Hwasong-18 ICBMs Fully Deployed For “Surprise” Nuclear Strike On U.S. Mainland

North Korea has developed 13 nuclear and missile weapons since 2021, with several now operational, including the Hwasong-18 ICBM.

Health

How Samsung Medical Center Reduced Waste by 80%: A Game-Changer in ESG Management

Hospitals face pressure to adopt eco-friendly practices due to rising concerns over waste and disposable items impacting the environment.

Q901: The Promising New Hope for Pediatric Brain Tumors – What You Need to Know About This FDA-Approved Therapy

Qurient, the major shareholder of DongKoo Bio&Pharma, received FDA approval for a pediatric brain tumor trial of Q901.

IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment?

IKS014 shows a 50% objective response rate in HER2-positive breast cancer patients previously treated with Enhertu.

IMB-105: The Next Breakthrough in Autoimmune Disease Treatment?

IMBiologics partners with GC Pharma to develop next-generation autoimmune disease treatments.

How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO

Trust is essential for Korean medical technology to enter foreign markets, according to Jeon Sang-hoon, CEO of Health On Cloud.
Latest

Nearly Half of OB-GYN Clinics Shift Away From Maternity Care, Study Finds

A study reveals 4 out of 10 OB-GYN specialists do not display their specialty, with many shifting to cosmetic procedures instead.

South Korea Launches $36 Million Medical AI Testbed Program for Real-World Clinical Trials

South Korea launches a $36M initiative for medical AI testing, supporting SMEs and startups in real-world healthcare applications.

GIST’s Breakthrough in Gene Diagnosis: A Game-Changer for Cancer and Infectious Disease Testing

GIST unveils a versatile genetic diagnostic platform, enhancing detection across diseases while simplifying design and improving efficiency.

South Korea to Lead Global Digital Healthcare Standardization Efforts

Asia is poised to lead in digital healthcare standardization, hosting an ISO meeting to enhance global interoperability in health informatics.

Eli Lilly’s New Weight Loss Pill Foundayo: A Game Changer in the GLP-1 Market?

The FDA has approved Eli Lilly's oral obesity drug Foundayo, enhancing competition in the weight loss market with flexible dosing.

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

AITRICS Achieves MDSAP Certification: What This Means for Global Medical Device Standards

AITRICS gains MDSAP certification, enhancing its global market entry and demonstrating compliance with international quality standards.

SANDRO Dual 2026: The Next Big Thing in Laser Hair Removal Approved by Japan and Taiwan

Wontech's SANDRO Dual 2026 laser device gains certifications in Japan and Taiwan, enhancing its global market presence in cosmetic procedures.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

Seragem’s Groundbreaking Hybrid Simulation Technology: What You Need to Know About Its Impact on Medical Devices

Ceragem Clinical's human simulation model enhances healthcare device efficiency, published in Annals of Biomedical Engineering.

Samsung Biologics Wins “Sustainability Leadership” at CDMO Awards: What This Means for the Future of Biopharma

Samsung Biologics wins the Sustainability Leadership award, marking a 13-year streak and highlighting its commitment to sustainable practices.

How Long-Term Use of Anticholinergic Medications Increases Fracture Risk by 65% in Seniors

A study reveals older adults on long-term medications face a 43% higher fracture risk, emphasizing the danger of anticholinergic drugs.

KIMES 2026: Record-Breaking Medical Expo Achieves 2.3 Trillion USD in Domestic Deals!

KIMES 2026 set attendance records with 75,003 visitors, generating 1.5 billion USD in domestic consultations and 450 million USD in exports.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.